RADHA VENKATARAMANAN

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health NEWARK, NJ NPI 1740620145

General Payments — all program years on this page

$1,832.26

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 122
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $371.47 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $371.4722

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $882.2064
2022 $561.9235
2023 $16.671
2024 $371.4722

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086360498 Bayer Healthcare Pharmaceuticals Inc. $23.92 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100649899 Novo Nordisk Inc $20.09 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105331724 AstraZeneca Pharmaceuticals LP $16.79 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116526082 GlaxoSmithKline, LLC. $16.96 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116559411 GlaxoSmithKline, LLC. $15.62 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116579090 GlaxoSmithKline, LLC. $15.42 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117406468 Amgen Inc. $18.46 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117406470 Amgen Inc. $18.66 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117709064 Amgen Inc. $11.97 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117709066 Amgen Inc. $16.22 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117709068 Amgen Inc. $16.22 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117709070 Amgen Inc. $15.88 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117709072 Amgen Inc. $16.14 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117709074 Amgen Inc. $16.14 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117709076 Amgen Inc. $16.26 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117709078 Amgen Inc. $16.96 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118136362 Boehringer Ingelheim Pharmaceuticals, Inc. $17.00 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135924682 Lilly USA, LLC $16.70 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135925074 Lilly USA, LLC $18.91 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135929472 Lilly USA, LLC $13.74 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135947031 Lilly USA, LLC $14.73 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139836554 SANOFI-AVENTIS U.S. LLC $18.68 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.